drug

Inhibitory TMS

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Mclean Hospital
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
NCT02642029—Completed

KOLs & investigators

1
Ann K Shinn, MD, MPHKOL score 2

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Mclean Hospital
company
trial
Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study
NA
trial
indication
Schizophrenia
indication
Bipolar Disorder I
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Ann K Shinn, MD, MPH
KOL score 2
person